Bucha et al. demonstrated in a model of Huntington’s disease that miR-214 directly targets MFN2, with its upregulation leading to decreased MFN2 levels, thus disturbing the mitochondrial fusion-fission balance, resulting in impaired fusion and increased fragmentation (Bucha et al., 2015). This evidence concerns the gene MFN2 and Huntington disease.